Mifobate是一种选择性的 PPARγ 拮抗剂,能够减弱 troglitazone 诱导的 PPARγ 转录活性,IC50 为 140μM。它能抑制 PPARγ 依赖的脂肪细胞分化和增殖,改善糖尿病 ob/ob 小鼠的胰岛素敏感性,并增加大鼠体内的 HDL 水平。
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
产品名称 | PPARα ↓ ↑ | PPARβ/δ ↓ ↑ | PPARγ ↓ ↑ | PPARδ ↓ ↑ | 其他靶点 | 纯度 | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Fenofibric acid | ✔ | 98% | |||||||||||||||||
GW6471 |
++
PPARα, IC50: 0.24 μM |
99%+ | |||||||||||||||||
GSK3787 |
++
PPARδ, pIC50: 6.6 |
++
PPARδ, pIC50: 6.6 |
99%+ | ||||||||||||||||
FH535 | ✔ | 98%+ | |||||||||||||||||
GW9662 |
+++
PPARα, IC50: 32 nM |
+++
PPARγ, IC50: 3.3 nM |
98% | ||||||||||||||||
T0070907 |
++++
PPARγ, IC50: 1 nM |
98% | |||||||||||||||||
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 |
描述 | PPARγ is expressed predominantly in adipose tissue, where it is known to play a critical role in adipocyte differentiation and fat deposition. Its synthetic ligands, the thiazolidinediones (TZD), are used as insulin sensitizers in the treatment of type 2 diabetes. SR-202 is a selective PPARγ antagonist, which is able to antagonize TZD-induced transcriptional activity of PPAR γ with an IC50 of 140 μM. In preadipocyte 3T3-L1 cells, treatment with SR-202 at different concentrations for 24h was able to significantly inhibit BRL 49653- and hormone-induced adipocyte differentiation of 3T3-L1 cells in a dose-dependent manner. The antiadipogenic effect of SR-202 was also revealed by the reduced expression of an adipocyte differentiation marker, the adipocyte fatty acid binding protein (aP2). In vivo, wild-type (wt) mice treated with SR-202 for 10 wk gained significantly less body weight than untreated wt mice under both SD (standard diet) and HFD (high fat diet). Consistent with this result, the treatment of wt mice by SR-202 significantly decreased WAT (white adipose tissue) mass under SD and protected them from HFD-induced increase in WAT mass. Moreover, treating PPAR/mice with SR-202 further decreased plasma levels of leptin and TNFα under HFD, whereas only leptin was further decreased under SD[1]. |
计算器 | ||||
存储液制备 | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
2.79mL 0.56mL 0.28mL |
13.94mL 2.79mL 1.39mL |
27.88mL 5.58mL 2.79mL |
CAS号 | 76541-72-5 |
分子式 | C11H17ClO7P2 |
分子量 | 358.649 |
别名 | Sr 202 |
运输 | 蓝冰 |
存储条件 |
In solvent -20°C:3-6个月-80°C:12个月 Pure form Inert atmosphere,Store in freezer, under -20°C |
溶解方案 |
DMSO: 105 mg/mL(292.77 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO H2O: 35 mg/mL(97.59 mM) 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
动物实验配方 |